234 related articles for article (PubMed ID: 20523244)
21. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
Niihori T; Aoki Y; Narumi Y; Neri G; Cavé H; Verloes A; Okamoto N; Hennekam RC; Gillessen-Kaesbach G; Wieczorek D; Kavamura MI; Kurosawa K; Ohashi H; Wilson L; Heron D; Bonneau D; Corona G; Kaname T; Naritomi K; Baumann C; Matsumoto N; Kato K; Kure S; Matsubara Y
Nat Genet; 2006 Mar; 38(3):294-6. PubMed ID: 16474404
[TBL] [Abstract][Full Text] [Related]
22. An adult case of cardiofaciocutaneous syndrome with BRAF mutation.
Sato S; Hida T; Okura M; Ishikawa A; Yamashita T
Eur J Dermatol; 2017 Aug; 27(4):412-413. PubMed ID: 28524057
[No Abstract] [Full Text] [Related]
23. New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.
Inoue S; Moriya M; Watanabe Y; Miyagawa-Tomita S; Niihori T; Oba D; Ono M; Kure S; Ogura T; Matsubara Y; Aoki Y
Hum Mol Genet; 2014 Dec; 23(24):6553-66. PubMed ID: 25035421
[TBL] [Abstract][Full Text] [Related]
24. Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome.
Gripp KW; Lin AE; Nicholson L; Allen W; Cramer A; Jones KL; Kutz W; Peck D; Rebolledo MA; Wheeler PG; Wilson W; Al-Rahawan MM; Stabley DL; Sol-Church K
Am J Med Genet A; 2007 Jul; 143A(13):1472-80. PubMed ID: 17551924
[TBL] [Abstract][Full Text] [Related]
25. Cardio-facio-cutaneous syndrome: does genotype predict phenotype?
Allanson JE; Annerén G; Aoki Y; Armour CM; Bondeson ML; Cave H; Gripp KW; Kerr B; Nystrom AM; Sol-Church K; Verloes A; Zenker M
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):129-35. PubMed ID: 21495173
[TBL] [Abstract][Full Text] [Related]
26. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
[TBL] [Abstract][Full Text] [Related]
27. Craniosynostosis in patients with RASopathies: Accumulating clinical evidence for expanding the phenotype.
Ueda K; Yaoita M; Niihori T; Aoki Y; Okamoto N
Am J Med Genet A; 2017 Sep; 173(9):2346-2352. PubMed ID: 28650561
[TBL] [Abstract][Full Text] [Related]
28. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
[TBL] [Abstract][Full Text] [Related]
29. Nevus cells of cardiofaciocutaneous syndrome bear BRAF germ-line and somatic double mutations.
Hida T; Sato S; Okura M; Uhara H
Eur J Dermatol; 2018 Oct; 28(5):704-705. PubMed ID: 30406758
[No Abstract] [Full Text] [Related]
30. Familial cardiofaciocutaneous syndrome in a father and a son with a novel MEK2 mutation.
Karaer K; Lissewski C; Zenker M
Am J Med Genet A; 2015 Feb; 167A(2):385-8. PubMed ID: 25487361
[TBL] [Abstract][Full Text] [Related]
31. PTPN11 mutations are not responsible for the Cardiofaciocutaneous (CFC) syndrome.
Kavamura MI; Pomponi MG; Zollino M; Lecce R; Murdolo M; Brunoni D; Alchorne MM; Opitz JM; Neri G
Eur J Hum Genet; 2003 Jan; 11(1):64-8. PubMed ID: 12529707
[TBL] [Abstract][Full Text] [Related]
32. Clinical and molecular analysis of RASopathies in a group of Turkish patients.
Şimşek-Kiper PÖ; Alanay Y; Gülhan B; Lissewski C; Türkyilmaz D; Alehan D; Cetin M; Utine GE; Zenker M; Boduroğlu K
Clin Genet; 2013 Feb; 83(2):181-6. PubMed ID: 22420426
[TBL] [Abstract][Full Text] [Related]
33. The cardiofaciocutaneous syndrome: prenatal findings in two patients.
Witters I; Denayer E; Brems H; Fryns JP; Legius E
Prenat Diagn; 2008 Jan; 28(1):53-5. PubMed ID: 18022830
[No Abstract] [Full Text] [Related]
34. Fibrous dysplasia in cardio-facio-cutaneous syndrome: A case report and review of literature.
Dong X; Png NCY; Fortier MV; Lim JY; Wong KPL; Choo JTL; Tan EC; Jamuar SS
Am J Med Genet A; 2022 Sep; 188(9):2732-2737. PubMed ID: 35801299
[TBL] [Abstract][Full Text] [Related]
35. Impaired Osteogenesis of Disease-Specific Induced Pluripotent Stem Cells Derived from a CFC Syndrome Patient.
Choi JY; Han KM; Kim D; Lee BH; Yoo HW; Choi JH; Han YM
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194391
[TBL] [Abstract][Full Text] [Related]
36. Neurological complications of cardio-facio-cutaneous syndrome.
Yoon G; Rosenberg J; Blaser S; Rauen KA
Dev Med Child Neurol; 2007 Dec; 49(12):894-9. PubMed ID: 18039235
[TBL] [Abstract][Full Text] [Related]
37. Eyelid nystagmus in a child with cardiofaciocutaneous syndrome associated with BRAF mutation.
Wong BM; Matsumoto JH; Pineles SL
J AAPOS; 2022 Apr; 26(2):95-97. PubMed ID: 35149204
[TBL] [Abstract][Full Text] [Related]
38. Is diagnosing cardio-facio-cutaneous (CFC) syndrome still a challenge? Delineation of the phenotype in 15 Polish patients with proven mutations, including novel mutations in the BRAF1 gene.
Ciara E; Pelc M; Jurkiewicz D; Kugaudo M; Gieruszczak-Białek D; Skórka A; Posmyk R; Jakubiuk-Tomaszuk A; Cieślikowska A; Chrzanowska KH; Jezela-Stanek A; Krajewska-Walasek M
Eur J Med Genet; 2015 Jan; 58(1):14-20. PubMed ID: 25463315
[TBL] [Abstract][Full Text] [Related]
39. Leucine-485 deletion variant of BRAF may exhibit the severe end of the clinical spectrum of CFC syndrome.
Suzuki-Muromoto S; Miyabayashi T; Nagai K; Yamamura-Suzuki S; Anzai M; Takezawa Y; Sato R; Okubo Y; Endo W; Inui T; Togashi N; Kikuchi A; Niihori T; Aoki Y; Kure S; Haginoya K
J Hum Genet; 2019 May; 64(5):499-504. PubMed ID: 30842599
[TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome.
Urosevic J; Sauzeau V; Soto-Montenegro ML; Reig S; Desco M; Wright EM; Cañamero M; Mulero F; Ortega S; Bustelo XR; Barbacid M
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5015-20. PubMed ID: 21383153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
